HEADER IMMUNE SYSTEM 15-NOV-17 6BMK TITLE CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTIGEN-PRESENTING GLYCOPROTEIN CD1D2; COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 7 CHAIN: B, D; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: CD1D2, CD1.2; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: MOUSE; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 GENE: B2M; SOURCE 13 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 274590 KEYWDS MAJOR HISTOCOMPATIBILITY COMPLEX, MHC-I, CD1D, ANTIGEN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR Y.B.KHANDOKAR,J.LE NOURS,J.ROSSJOHN REVDAT 5 04-OCT-23 6BMK 1 REMARK HETSYN REVDAT 4 29-JUL-20 6BMK 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 07-MAR-18 6BMK 1 COMPND REMARK HET HETNAM REVDAT 3 2 1 HETSYN FORMUL ATOM REVDAT 2 21-FEB-18 6BMK 1 JRNL REVDAT 1 31-JAN-18 6BMK 0 JRNL AUTH S.SUNDARARAJ,J.ZHANG,S.H.KROVI,R.BEDEL,K.D.TUTTLE, JRNL AUTH 2 N.VEERAPEN,G.S.BESRA,Y.KHANDOKAR,T.PRAVEENA,J.LE NOURS, JRNL AUTH 3 J.L.MATSUDA,J.ROSSJOHN,L.GAPIN JRNL TITL DIFFERING ROLES OF CD1D2 AND CD1D1 PROTEINS IN TYPE I JRNL TITL 2 NATURAL KILLER T CELL DEVELOPMENT AND FUNCTION. JRNL REF PROC. NATL. ACAD. SCI. V. 115 E1204 2018 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 29351991 JRNL DOI 10.1073/PNAS.1716669115 REMARK 2 REMARK 2 RESOLUTION. 2.43 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 32070 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1627 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.43 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.20 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2873 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2606 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2721 REMARK 3 BIN R VALUE (WORKING SET) : 0.2588 REMARK 3 BIN FREE R VALUE : 0.2916 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.29 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 152 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5838 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 164 REMARK 3 SOLVENT ATOMS : 64 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.98890 REMARK 3 B22 (A**2) : -6.47410 REMARK 3 B33 (A**2) : -5.51480 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.63060 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.355 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.429 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.254 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.464 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.262 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.908 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6187 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8433 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2775 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 137 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 894 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6187 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 807 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6744 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.52 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.07 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BMK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1000231127. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0-6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32070 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.430 REMARK 200 RESOLUTION RANGE LOW (A) : 45.770 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.8800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.52 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1CD1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BISTRIS (PH 6-6.5), 200 MM REMARK 280 CACL2 AND 21-26% PEG 3350, PH 6.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.77450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 4 REMARK 465 GLN A 5 REMARK 465 LYS A 6 REMARK 465 ASN A 7 REMARK 465 ILE B 1 REMARK 465 GLN C 4 REMARK 465 GLN C 5 REMARK 465 LYS C 6 REMARK 465 ASN C 7 REMARK 465 ILE D 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 21 CG1 CG2 CD1 REMARK 470 LYS A 86 CG CD CE NZ REMARK 470 LYS A 91 CG CD CE NZ REMARK 470 ASP A 93 CG OD1 OD2 REMARK 470 ASN A 110 CG OD1 ND2 REMARK 470 ARG A 173 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 180 CG CD CE NZ REMARK 470 LYS A 185 CG CD CE NZ REMARK 470 GLN A 273 CG CD OE1 NE2 REMARK 470 LYS B 3 CG CD CE NZ REMARK 470 LYS B 19 CG CD CE NZ REMARK 470 LYS B 44 CG CD CE NZ REMARK 470 LYS B 48 CG CD CE NZ REMARK 470 LYS B 58 CG CD CE NZ REMARK 470 LYS B 83 CG CD CE NZ REMARK 470 GLN C 61 CG CD OE1 NE2 REMARK 470 LYS C 91 CG CD CE NZ REMARK 470 ASN C 110 CG OD1 ND2 REMARK 470 GLU C 113 CG CD OE1 OE2 REMARK 470 LEU C 137 CG CD1 CD2 REMARK 470 GLN C 154 CG CD OE1 NE2 REMARK 470 GLN C 170 CG CD OE1 NE2 REMARK 470 LYS C 180 CG CD CE NZ REMARK 470 LYS C 185 CG CD CE NZ REMARK 470 HIS C 201 CG ND1 CD2 CE1 NE2 REMARK 470 GLN C 205 CG CD OE1 NE2 REMARK 470 GLU C 254 CG CD OE1 OE2 REMARK 470 GLU C 257 CG CD OE1 OE2 REMARK 470 GLN C 273 CG CD OE1 NE2 REMARK 470 GLN D 2 CG CD OE1 NE2 REMARK 470 GLU D 16 CG CD OE1 OE2 REMARK 470 LYS D 19 CG CD CE NZ REMARK 470 GLU D 36 CG CD OE1 OE2 REMARK 470 LYS D 44 CG CD CE NZ REMARK 470 LYS D 45 CG CD CE NZ REMARK 470 LYS D 48 CG CD CE NZ REMARK 470 LYS D 58 CG CD CE NZ REMARK 470 LYS D 83 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASN A 110 CB REMARK 480 ASN C 110 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 90 41.15 -85.88 REMARK 500 LYS A 91 -59.17 70.54 REMARK 500 ASN A 110 10.70 58.38 REMARK 500 ASP A 166 -55.89 -122.19 REMARK 500 ALA A 200 129.38 172.46 REMARK 500 GLN B 29 17.81 59.07 REMARK 500 ASN C 110 10.81 58.12 REMARK 500 ALA C 125 -44.07 -130.34 REMARK 500 ASP C 166 -55.82 -122.00 REMARK 500 ALA C 200 131.85 172.40 REMARK 500 ARG C 224 76.53 -116.96 REMARK 500 GLN D 29 19.59 57.56 REMARK 500 REMARK 500 REMARK: NULL DBREF 6BMK A 4 279 UNP P11610 CD1D2_MOUSE 22 297 DBREF 6BMK B 1 99 UNP P01887 B2MG_MOUSE 21 119 DBREF 6BMK C 4 279 UNP P11610 CD1D2_MOUSE 22 297 DBREF 6BMK D 1 99 UNP P01887 B2MG_MOUSE 21 119 SEQADV 6BMK ILE A 46 UNP P11610 THR 64 CONFLICT SEQADV 6BMK ILE C 46 UNP P11610 THR 64 CONFLICT SEQRES 1 A 276 GLN GLN LYS ASN TYR THR PHE ARG CYS LEU GLN THR SER SEQRES 2 A 276 SER PHE ALA ASN ILE SER TRP SER ARG THR ASP SER LEU SEQRES 3 A 276 ILE LEU LEU GLY ASP LEU GLN THR HIS ARG TRP SER ASN SEQRES 4 A 276 ASP SER ALA ILE ILE SER PHE THR LYS PRO TRP SER GLN SEQRES 5 A 276 GLY LYS LEU SER ASN GLN GLN TRP GLU LYS LEU GLN HIS SEQRES 6 A 276 MET PHE GLN VAL TYR ARG VAL SER PHE THR ARG ASP ILE SEQRES 7 A 276 GLN GLU LEU VAL LYS MET MET SER PRO LYS GLU ASP TYR SEQRES 8 A 276 PRO ILE GLU ILE GLN LEU SER THR GLY CYS GLU MET TYR SEQRES 9 A 276 PRO GLY ASN ALA SER GLU SER PHE PHE HIS VAL ALA PHE SEQRES 10 A 276 GLN GLY LYS TYR ALA VAL ARG PHE ARG GLY THR SER TRP SEQRES 11 A 276 GLN ARG VAL LEU GLY ALA PRO SER TRP LEU ASP LEU PRO SEQRES 12 A 276 ILE LYS VAL LEU ASN ALA ASP GLN GLY THR SER ALA THR SEQRES 13 A 276 VAL GLN THR LEU LEU ASN ASP THR TRP PRO GLN PHE ALA SEQRES 14 A 276 ARG GLY LEU LEU GLU ALA GLY LYS SER ASP LEU GLU LYS SEQRES 15 A 276 GLN GLU LYS PRO VAL ALA TRP LEU SER SER VAL PRO SER SEQRES 16 A 276 SER ALA HIS GLY HIS LEU GLN LEU VAL CYS HIS VAL SER SEQRES 17 A 276 GLY PHE TYR PRO LYS PRO VAL TRP VAL MET TRP MET ARG SEQRES 18 A 276 GLY ASP GLN GLU GLN GLN GLY THR HIS ARG GLY ASP PHE SEQRES 19 A 276 LEU PRO ASN ALA ASP GLU THR TRP TYR LEU GLN ALA THR SEQRES 20 A 276 LEU ASP VAL GLU ALA GLY GLU GLU ALA GLY LEU ALA CYS SEQRES 21 A 276 ARG VAL LYS HIS SER SER LEU GLY GLY GLN ASP ILE ILE SEQRES 22 A 276 LEU TYR TRP SEQRES 1 B 99 ILE GLN LYS THR PRO GLN ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO PRO GLU ASN GLY LYS PRO ASN ILE LEU ASN CYS TYR SEQRES 3 B 99 VAL THR GLN PHE HIS PRO PRO HIS ILE GLU ILE GLN MET SEQRES 4 B 99 LEU LYS ASN GLY LYS LYS ILE PRO LYS VAL GLU MET SER SEQRES 5 B 99 ASP MET SER PHE SER LYS ASP TRP SER PHE TYR ILE LEU SEQRES 6 B 99 ALA HIS THR GLU PHE THR PRO THR GLU THR ASP THR TYR SEQRES 7 B 99 ALA CYS ARG VAL LYS HIS ALA SER MET ALA GLU PRO LYS SEQRES 8 B 99 THR VAL TYR TRP ASP ARG ASP MET SEQRES 1 C 276 GLN GLN LYS ASN TYR THR PHE ARG CYS LEU GLN THR SER SEQRES 2 C 276 SER PHE ALA ASN ILE SER TRP SER ARG THR ASP SER LEU SEQRES 3 C 276 ILE LEU LEU GLY ASP LEU GLN THR HIS ARG TRP SER ASN SEQRES 4 C 276 ASP SER ALA ILE ILE SER PHE THR LYS PRO TRP SER GLN SEQRES 5 C 276 GLY LYS LEU SER ASN GLN GLN TRP GLU LYS LEU GLN HIS SEQRES 6 C 276 MET PHE GLN VAL TYR ARG VAL SER PHE THR ARG ASP ILE SEQRES 7 C 276 GLN GLU LEU VAL LYS MET MET SER PRO LYS GLU ASP TYR SEQRES 8 C 276 PRO ILE GLU ILE GLN LEU SER THR GLY CYS GLU MET TYR SEQRES 9 C 276 PRO GLY ASN ALA SER GLU SER PHE PHE HIS VAL ALA PHE SEQRES 10 C 276 GLN GLY LYS TYR ALA VAL ARG PHE ARG GLY THR SER TRP SEQRES 11 C 276 GLN ARG VAL LEU GLY ALA PRO SER TRP LEU ASP LEU PRO SEQRES 12 C 276 ILE LYS VAL LEU ASN ALA ASP GLN GLY THR SER ALA THR SEQRES 13 C 276 VAL GLN THR LEU LEU ASN ASP THR TRP PRO GLN PHE ALA SEQRES 14 C 276 ARG GLY LEU LEU GLU ALA GLY LYS SER ASP LEU GLU LYS SEQRES 15 C 276 GLN GLU LYS PRO VAL ALA TRP LEU SER SER VAL PRO SER SEQRES 16 C 276 SER ALA HIS GLY HIS LEU GLN LEU VAL CYS HIS VAL SER SEQRES 17 C 276 GLY PHE TYR PRO LYS PRO VAL TRP VAL MET TRP MET ARG SEQRES 18 C 276 GLY ASP GLN GLU GLN GLN GLY THR HIS ARG GLY ASP PHE SEQRES 19 C 276 LEU PRO ASN ALA ASP GLU THR TRP TYR LEU GLN ALA THR SEQRES 20 C 276 LEU ASP VAL GLU ALA GLY GLU GLU ALA GLY LEU ALA CYS SEQRES 21 C 276 ARG VAL LYS HIS SER SER LEU GLY GLY GLN ASP ILE ILE SEQRES 22 C 276 LEU TYR TRP SEQRES 1 D 99 ILE GLN LYS THR PRO GLN ILE GLN VAL TYR SER ARG HIS SEQRES 2 D 99 PRO PRO GLU ASN GLY LYS PRO ASN ILE LEU ASN CYS TYR SEQRES 3 D 99 VAL THR GLN PHE HIS PRO PRO HIS ILE GLU ILE GLN MET SEQRES 4 D 99 LEU LYS ASN GLY LYS LYS ILE PRO LYS VAL GLU MET SER SEQRES 5 D 99 ASP MET SER PHE SER LYS ASP TRP SER PHE TYR ILE LEU SEQRES 6 D 99 ALA HIS THR GLU PHE THR PRO THR GLU THR ASP THR TYR SEQRES 7 D 99 ALA CYS ARG VAL LYS HIS ALA SER MET ALA GLU PRO LYS SEQRES 8 D 99 THR VAL TYR TRP ASP ARG ASP MET HET NAG E 1 14 HET NAG E 2 14 HET NAG F 1 14 HET NAG F 2 14 HET NAG A 501 14 HET F57 A 504 40 HET NAG C 501 14 HET F57 C 504 40 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM F57 (2R)-1-(DECANOYLOXY)-3-(PHOSPHONOOXY)PROPAN-2-YL HETNAM 2 F57 OCTADECANOATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 NAG 6(C8 H15 N O6) FORMUL 8 F57 2(C31 H61 O8 P) FORMUL 11 HOH *64(H2 O) HELIX 1 AA1 SER A 59 MET A 88 1 30 HELIX 2 AA2 PRO A 140 TRP A 142 5 3 HELIX 3 AA3 LEU A 143 ASP A 153 1 11 HELIX 4 AA4 ASP A 153 ASP A 166 1 14 HELIX 5 AA5 ASP A 166 GLY A 179 1 14 HELIX 6 AA6 GLY A 179 LYS A 185 1 7 HELIX 7 AA7 HIS A 267 GLY A 271 5 5 HELIX 8 AA8 SER C 59 SER C 89 1 31 HELIX 9 AA9 PRO C 140 TRP C 142 5 3 HELIX 10 AB1 LEU C 143 ALA C 152 1 10 HELIX 11 AB2 ASP C 153 ASP C 166 1 14 HELIX 12 AB3 ASP C 166 LYS C 185 1 20 HELIX 13 AB4 HIS C 267 GLY C 271 5 5 SHEET 1 AA1 8 SER A 48 PHE A 49 0 SHEET 2 AA1 8 LEU A 35 TRP A 40 -1 N ARG A 39 O SER A 48 SHEET 3 AA1 8 SER A 24 LEU A 32 -1 N SER A 28 O TRP A 40 SHEET 4 AA1 8 THR A 9 PHE A 18 -1 N THR A 15 O ASP A 27 SHEET 5 AA1 8 ILE A 96 TYR A 107 -1 O ILE A 98 N SER A 16 SHEET 6 AA1 8 ALA A 111 PHE A 120 -1 O HIS A 117 N SER A 101 SHEET 7 AA1 8 LYS A 123 ARG A 129 -1 O ALA A 125 N VAL A 118 SHEET 8 AA1 8 SER A 132 ARG A 135 -1 O GLN A 134 N ARG A 127 SHEET 1 AA2 4 VAL A 190 PRO A 197 0 SHEET 2 AA2 4 HIS A 203 PHE A 213 -1 O VAL A 207 N SER A 194 SHEET 3 AA2 4 TRP A 245 GLU A 254 -1 O LEU A 251 N LEU A 206 SHEET 4 AA2 4 HIS A 233 ARG A 234 -1 N HIS A 233 O THR A 250 SHEET 1 AA3 4 VAL A 190 PRO A 197 0 SHEET 2 AA3 4 HIS A 203 PHE A 213 -1 O VAL A 207 N SER A 194 SHEET 3 AA3 4 TRP A 245 GLU A 254 -1 O LEU A 251 N LEU A 206 SHEET 4 AA3 4 LEU A 238 PRO A 239 -1 N LEU A 238 O TYR A 246 SHEET 1 AA4 4 GLN A 227 GLU A 228 0 SHEET 2 AA4 4 TRP A 219 ARG A 224 -1 N ARG A 224 O GLN A 227 SHEET 3 AA4 4 LEU A 261 LYS A 266 -1 O ALA A 262 N MET A 223 SHEET 4 AA4 4 ILE A 275 TYR A 278 -1 O LEU A 277 N CYS A 263 SHEET 1 AA5 4 GLN B 6 SER B 11 0 SHEET 2 AA5 4 ASN B 21 THR B 28 -1 O ASN B 24 N TYR B 10 SHEET 3 AA5 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 AA5 4 GLU B 50 MET B 51 -1 N GLU B 50 O HIS B 67 SHEET 1 AA6 4 GLN B 6 SER B 11 0 SHEET 2 AA6 4 ASN B 21 THR B 28 -1 O ASN B 24 N TYR B 10 SHEET 3 AA6 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 AA6 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 AA7 4 LYS B 44 LYS B 45 0 SHEET 2 AA7 4 GLU B 36 LYS B 41 -1 N LYS B 41 O LYS B 44 SHEET 3 AA7 4 TYR B 78 LYS B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 AA7 4 LYS B 91 TYR B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 AA8 8 SER C 48 PHE C 49 0 SHEET 2 AA8 8 LEU C 35 TRP C 40 -1 N ARG C 39 O SER C 48 SHEET 3 AA8 8 SER C 24 LEU C 32 -1 N SER C 28 O TRP C 40 SHEET 4 AA8 8 THR C 9 PHE C 18 -1 N THR C 15 O ASP C 27 SHEET 5 AA8 8 ILE C 96 TYR C 107 -1 O ILE C 98 N SER C 16 SHEET 6 AA8 8 ALA C 111 PHE C 120 -1 O HIS C 117 N SER C 101 SHEET 7 AA8 8 LYS C 123 ARG C 129 -1 O ALA C 125 N VAL C 118 SHEET 8 AA8 8 SER C 132 ARG C 135 -1 O GLN C 134 N ARG C 127 SHEET 1 AA9 4 VAL C 190 PRO C 197 0 SHEET 2 AA9 4 HIS C 203 PHE C 213 -1 O VAL C 207 N SER C 194 SHEET 3 AA9 4 TRP C 245 GLU C 254 -1 O LEU C 251 N LEU C 206 SHEET 4 AA9 4 HIS C 233 ARG C 234 -1 N HIS C 233 O THR C 250 SHEET 1 AB1 4 VAL C 190 PRO C 197 0 SHEET 2 AB1 4 HIS C 203 PHE C 213 -1 O VAL C 207 N SER C 194 SHEET 3 AB1 4 TRP C 245 GLU C 254 -1 O LEU C 251 N LEU C 206 SHEET 4 AB1 4 LEU C 238 PRO C 239 -1 N LEU C 238 O TYR C 246 SHEET 1 AB2 4 GLN C 227 GLU C 228 0 SHEET 2 AB2 4 TRP C 219 ARG C 224 -1 N ARG C 224 O GLN C 227 SHEET 3 AB2 4 LEU C 261 LYS C 266 -1 O ALA C 262 N MET C 223 SHEET 4 AB2 4 ILE C 275 TYR C 278 -1 O LEU C 277 N CYS C 263 SHEET 1 AB3 4 GLN D 6 SER D 11 0 SHEET 2 AB3 4 ASN D 21 THR D 28 -1 O ASN D 24 N TYR D 10 SHEET 3 AB3 4 PHE D 62 PHE D 70 -1 O THR D 68 N LEU D 23 SHEET 4 AB3 4 GLU D 50 MET D 51 -1 N GLU D 50 O HIS D 67 SHEET 1 AB4 4 GLN D 6 SER D 11 0 SHEET 2 AB4 4 ASN D 21 THR D 28 -1 O ASN D 24 N TYR D 10 SHEET 3 AB4 4 PHE D 62 PHE D 70 -1 O THR D 68 N LEU D 23 SHEET 4 AB4 4 SER D 55 PHE D 56 -1 N SER D 55 O TYR D 63 SHEET 1 AB5 4 LYS D 44 LYS D 45 0 SHEET 2 AB5 4 GLU D 36 LYS D 41 -1 N LYS D 41 O LYS D 44 SHEET 3 AB5 4 TYR D 78 LYS D 83 -1 O ALA D 79 N LEU D 40 SHEET 4 AB5 4 LYS D 91 TYR D 94 -1 O LYS D 91 N VAL D 82 SSBOND 1 CYS A 208 CYS A 263 1555 1555 2.03 SSBOND 2 CYS B 25 CYS B 80 1555 1555 2.02 SSBOND 3 CYS C 208 CYS C 263 1555 1555 2.01 SSBOND 4 CYS D 25 CYS D 80 1555 1555 2.05 LINK ND2 ASN A 42 C1 NAG A 501 1555 1555 1.44 LINK ND2 ASN A 165 C1 NAG E 1 1555 1555 1.43 LINK ND2 ASN C 42 C1 NAG C 501 1555 1555 1.43 LINK ND2 ASN C 165 C1 NAG F 1 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.43 CISPEP 1 TYR A 94 PRO A 95 0 2.81 CISPEP 2 TYR A 214 PRO A 215 0 0.15 CISPEP 3 HIS B 31 PRO B 32 0 5.33 CISPEP 4 SER C 89 PRO C 90 0 2.50 CISPEP 5 TYR C 94 PRO C 95 0 2.98 CISPEP 6 TYR C 214 PRO C 215 0 0.10 CISPEP 7 HIS D 31 PRO D 32 0 5.91 CRYST1 58.566 71.549 104.747 90.00 101.78 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017075 0.000000 0.003561 0.00000 SCALE2 0.000000 0.013976 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009752 0.00000